Beyond Steroids: Topical Dermatological Efficacy and Patient-Centric Perspectives

Experts in the management of skin conditions recap key insight from a roundtable discussion delving into unmet needs in non-steroidal topical treatment for atopic dermatitis. They discuss the safety, efficacy, and rapid itch relief of topical ruxolitinib, and offer insights on counseling patients about its black box warning. Furthermore, the program explores perceptions of limited treatment access and how to address this issue.